Literature DB >> 33368395

Screening donors for COVID-19 convalescent plasma.

Henry E Wang1, Luis Ostrosky-Zeichner2, Jeffrey Katz3, Audrey Wanger4, Yu Bai4, Sujatha Sridhar5, Bela Patel6.   

Abstract

BACKGROUND: Convalescent plasma is used as a treatment for COVID-19. Only limited data describe the efforts to recruit COVID-19 convalescent plasma (CCP) donors. We describe our experience engaging persons recovered from COVID-19 to donate CCP. STUDY DESIGN AND METHODS: We performed a retrospective analysis of the CCP recruitment for an 11-hospital health system in Houston, Texas. We sought CCP donations from: a) "volunteers" responding to advertisements in social media, press releases, and websites and b) "referred" individuals directed to the program or identified from hospitalization records. We determined the proportions of donor candidates who passed initial telephone health screening, who qualified after diagnostic testing, who presented to the regional CCP donation center, and who completed CCP donation.
RESULTS: There were 900 CCP donor candidates, including 363 volunteers and 537 referred donors. Of 360 contacted volunteers, 186 (5.7%) were excluded by interview; 133 were referred for additional diagnostic screening, 97 completed donor antibody and antigen testing, and 87 were qualified for CCP donation, resulting in 35 CCP donations (9.7% of initial telephone contacts). Among 533 referred donors, 448 (84.1%) were excluded by interview, 71 were referred for additional screening, 48 completed donor antibody and antigen testing, and 40 were qualified for CCP donation, resulting in one CCP donation (0.2% of initial telephone contacts).
CONCLUSION: In this community, screening of a high number of candidates yielded a limited number of CCP donations. These observations have important implications for CCP donor recruitment and community pandemic planning.
© 2021 AABB.

Entities:  

Keywords:  FFP transfusion; donors; transfusion practices (adult)

Mesh:

Year:  2021        PMID: 33368395     DOI: 10.1111/trf.16253

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  4 in total

1.  Knowledge and Attitudes of Young Adults Towards Donation of COVID-19 Convalescent Plasma and Its Therapeutic Properties.

Authors:  Lidia Perenc; Ryszard Pęczkowski
Journal:  J Blood Med       Date:  2021-08-10

2.  We stand ready … Blood collection organizations and the COVID-19 pandemic.

Authors:  Hany Kamel
Journal:  Transfusion       Date:  2021-05       Impact factor: 3.157

3.  A Rapid and Sensitive Microfluidics-Based Tool for Seroprevalence Immunity Assessment of COVID-19 and Vaccination-Induced Humoral Antibody Response at the Point of Care.

Authors:  Kritika Srinivasan Rajsri; Michael P McRae; Glennon W Simmons; Nicolaos J Christodoulides; Hanover Matz; Helen Dooley; Akiko Koide; Shohei Koide; John T McDevitt
Journal:  Biosensors (Basel)       Date:  2022-08-10

4.  Qualifying coronavirus disease 2019 convalescent plasma donors in Israel.

Authors:  Marina Izak; Veronica Gendelman; Sharron Bransburg-Zabary; Evgeniy Stoyanov; Roni Gat; Daniel Cohen; Jacob Chen; Yasmin Maor; Avi Benov; Boaz Lev; Oren Zimhony; Eilat Shinar
Journal:  Vox Sang       Date:  2021-06-14       Impact factor: 2.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.